生物製剤市場レポート：2022-2032

Biologics Market Report 2022-2032

レポート詳細生物製剤市場レポート 2022-2032 :本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなる... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
Visiongain ヴィジョンゲイン社	2022年7月4日	GBP4,500 部署ライセンスライセンス・価格情報注文方法はこちら	475	628	英語

※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

レポート詳細

生物製剤市場レポート 2022-2032:本レポートは、新たな収益の柱を目指すリーディングカンパニーが、業界とその背景にあるダイナミクスをより深く理解する上で、非常に有益なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有用なレポートです。

活発な研究開発と臨床試験への注力により、生物製剤市場は成長を続けている
積極的な研究開発と臨床試験の重視が、世界の生物製剤市場の成長を牽引しています。このようなR＆D活動により、生物製剤の臨床試験の成功率は向上しています。生物製剤市場の業界リーダーは、効果的で革新的な生物製剤という市場のイノベーションを生み出すために、R＆Dを行っています。生物製剤の価格は高く、その有効性から、生物製剤分野の企業は大きな利幅を有しています。何十年もの間、製薬会社は低分子化合物を中心に扱ってきましたが、この分野での発見速度が大幅に低下したため、生物製剤へと移行することになったのです。低分子化合物の約20倍の値段の生物製剤治療は、将来的に約40％〜45％の利益率を生み出すと予測されている。

ロジスティックとアドミニストレーションの課題
政府および規制機関は、生物製剤分野において重要な役割を果たしています。規制機関は、既存および新規の医薬品を対象とした新しい生物製剤市場の開拓のための規制手続きを維持しています。過去10年間、医薬品研究者は、革新的な生物製剤の臨床研究に対する主要市場の反発の高まりに直面し、希少疾患の新規治療法の上市が妨げられてきました。米国や欧州連合などの主要市場では、規制を強化・自由化し、臨床試験デザインを簡素化するための戦略的措置が講じられてきました。しかし、医薬品関連の医療プログラムに対する政府支出の増加は、業界の成功に不可欠です。

マーケットリサーチレポートを購入する前に、どのような質問をすべきでしょうか？
- 生物製剤市場はどのように進化しているのか？
- 生物製剤市場の推進要因と抑制要因は何か？
- 各生物製剤サブマーケットセグメントは予測期間中にどのように成長し、2032年にこれらのサブマーケットが占める収益はどの程度になるのか？
- 2022年から2032年にかけて、各生物製剤サブマーケットの市場シェアはどのように推移するのでしょうか？
- 2022年から2032年にかけて、市場全体の主なドライバーは何になるのか?
- 主要な生物製剤市場はマクロ経済のダイナミクスに概ね追随するのか、それとも個々の国内市場が他を凌駕するのか？
- 2032年までに各国市場のシェアはどのように変化し、どの地域が2032年の市場をリードするのでしょうか？
- 主要プレイヤーは誰か、また予測期間中の見通しは？
- これらの主要企業の生物製剤プロジェクトはどのようなものですか？
- 2022年から2032年の間に、業界はどのように進化するのでしょうか？現在および今後10年間に行われる生物製剤プロジェクトにはどのような意味があるのでしょうか？
- 生物製剤市場をさらに拡大するために、製品の商業化の必要性は高まっているのか？
- 生物製剤市場はどこに向かっているのか？そして、どのようにすれば市場の最前線にいることを確実にできるのか？
- 新製品やサービスラインに対する最適な投資オプションは何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望とは？

このことが、現在、そして今後10年間の生物製剤市場にどのような影響を与えるかを見極める必要があります。

- 475ページにわたる本レポートでは、308の表と320のグラフを独占的に提供します。
- このレポートでは、業界における主要な収益性の高い分野をハイライトしているため、今すぐターゲットを絞ることができます。
- 世界、地域、国内の売上と成長に関する詳細な分析が含まれています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。

本レポートは、生物製剤市場が今後10年間にどのように発展し、COVID-19の景気後退と回復の変動に沿ったものであることを今日あなたに伝えます。この市場は、過去10年間のどの時点よりも、今がより重要なのです。

COVID-19のバリエーションは、お客様の市場に特化した経済データを提供します。

2032年までの予測やその他の分析により、商業的な展望が明らかになる
- 2032年までの収益予測に加え、直近の実績、成長率、市場シェアも掲載。
- ビジネスの展望や展開など、独自の分析をご覧いただけます。
- 定性的分析（市場ダイナミクス、ドライバー、機会、阻害要因、課題など）、コスト構造、生物製剤の価格上昇の影響、最近の動向などをご覧いただけます。

本レポートでは、COVID-19が業界と貴社にどのような影響を与えるかについて、データ分析と貴重な洞察を掲載しています。本レポートでは、COVID-19の4つの回収パターンとその影響、すなわち「V」、「L」、「W」、「U」について論じています。

報告書の対象セグメント

製品タイプ
- モノクローナル抗体
- ワクチン
- タンパク質治療薬
- 融合タンパク質
- 再生医療

用途
- がん
- 自己免疫疾患
- 感染症
- 循環器疾患
- 血液疾患
- その他

製造
- アウトソーシング
- 社内

世界市場全体とセグメントの収益予測に加え、5地域と20の主要国市場の収益予測も掲載しています。

北米
- 米国
- カナダ

欧州
- ドイツ
- 英国
- フランス
- イタリア
- スペイン
- ロシア
- その他の欧州

アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 南朝鮮
- その他のアジア太平洋地域

ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ地域

中東・アフリカ
- GCC
- 南アフリカ
-その他のMEA

レポートには、バイオロジクス市場の主要企業数社の2022年から2032年までのプロフィールも掲載されており、これらの企業のこの分野に焦点を当てた内容となっています。

主要企業と市場成長の可能性
・ AbbVie Inc.
・ Amgen Inc.
・ Biogen
・ Bristol-Myers Squibb Company
・ Eli Lilly and Company
・ F. Hoffmann-La Roche Ltd
・ GlaxoSmithKline plc.
・ Johnson ＆ Johnson Services, Inc.
・ Merck KGaA
・ Novartis AG
・ NuVasive, Inc.
・ Novo Holdings A/S (Novo Nordisk A/S)
・ Organogenesis Holdings Inc.
・ ORTHOFIX INTERNATIONAL N.V.
・ Pfizer Inc.
・ Sanofi
・ Takeda Pharmaceutical Company Limited

生物製剤市場の世界全体の収益、2022年から2032年まで金額ベースで、2022年に3,828億5千万米ドルを突破すると、我々の仕事は計算しています。2032年まで力強い収益成長が予測される。本調査では、最も大きな可能性を秘めた組織を特定します。彼らの能力、進歩、商業的展望を知ることで、一歩先を行くことができます。

生物製剤市場、2022年から2032年までの市場レポートはどのようにあなたを助けるか？
470ページを超えるレポートでは、要約すると以下のような知識を得ることができます。

- 生物製剤市場の2022年から2032年までの収益予測。製品タイプ、用途、製造ごとに世界と地域レベルで予測-業界の展望を発見し、投資と収益の最も有利な場所を見つける。

- 5地域と22主要国市場の2032年までの収益予測 - 北米、欧州、アジア太平洋、中南米、MEAの生物製剤市場の2022年から2032年までの市場予測をご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなどの主要経済圏の市場も予測されています。

- 2022年から2032年までの生物製剤市場に関わる主要企業18社の企業プロファイルを含む、既存企業と市場参入を目指す企業の展望。

定量的・定性的な分析と独自の予測をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスを得ることができます。

他にはない情報
新しいレポートタイトルで、知識の遅れを取り戻し、チャンスを逃す可能性が低くなります。私たちの研究が貴社の研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、生物製剤市場、2022年から2032年までの市場や大手企業の商業的分析を必要とするすべての人のためのものです。データ、トレンド、予測を見つけることができます。

ページTOPに戻る

1.レポートの概要
1.1 生物製剤市場の紹介
1.2 生物製剤市場の定義
1.3 本レポートを読むべき理由
1.4 本レポートが提供するもの
1.5 本分析レポートが回答する主な質問には以下が含まれる。
1.6 本レポートは誰のためのものなのか？
1.7 方法論
1.7.1 一次調査
1.7.2 セカンダリーリサーチ
1.7.3 市場評価・予測手法
1.8 よくある質問（FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて

2 エグゼクティブサマリー

3 マーケットダイナミクス
3.1 ドライバ
3.1.1 バイオメディカル科学の進歩
3.1.2 新規生物学的製剤の開発資金の増加
3.1.3 複数の医薬品の特許切れ
3.2 制約要因
3.2.1 治験の厳しさと低回転率
3.2.2 バイオシミラーの開発による生物学的製剤の需要減退
3.3 機会
3.3.1 生物学的製剤はより多くの疾患領域に関連するようになりつつある
3.4 チャレンジ
3.4.1 生物学的製剤の開発における複雑さ
3.5 SWOT分析
3.5.1 強み
3.5.1.1 効果的な生物製剤の吸収と便利な自己投与へのニーズの高まりが、R&D投資の重要性を強調
3.5.2 弱点
3.5.2.1 革新的な生物製剤の失敗による財務的損失は長年の問題である
3.5.3 オポチュニティ
3.5.3.1 強力なパイプラインと進行中の膨大な数の臨床試験が市場成長の機会を提供している
3.5.3.2 将来的なナノテクノロジーの応用
3.5.4 脅威
3.5.4.1 低分子化合物
3.6 ポーターのファイブフォース分析
3.6.1 サプライヤーの交渉力:高い
3.6.2 バイヤーの交渉力:中程度
3.6.3 競争相手との競合：高
3.6.4 新規参入の脅威:中程度
3.6.5 代替品の脅威:低
3.7 PEST分析
3.7.1 生物製剤市場に影響を与える政治的要因
3.7.2 生物製剤市場に影響を与える経済的要因
3.7.3 生物製剤市場に影響を与える社会的要因
3.7.4 生物製剤市場に影響を与える技術的要因

4 生物製剤市場予測：製品タイプ別、2022-2032年
4.1 モノクローナル抗体のセグメント別市場予測、2022-2032年
4.1.1 モノクローナル抗体。最大のシェアを占める
4.1.2 回復シナリオ（V、U、W、L）
4.2 ワクチンセグメント市場予測、2022年～2032年
4.2.1 ワクチン製造は大手4社に集中している
4.2.2 回復シナリオ（V、U、W、L)
4.3 タンパク質治療薬セグメントの市場予測、2022年～2032年
4.3.1 タンパク質治療薬の有用性に関する社会的認知度の向上
4.3.2 回復シナリオ（V, U, W, L)
4.4 再生医療セグメントの市場予測、2022年〜2032年
4.4.1 再生医療を支持する政府の政策
4.4.2 回復シナリオ（V,U,W,L）
4.5 融合タンパク質セグメントの市場予測、2022年～2032年
4.5.1 糖尿病の増加により融合タンパク質の需要が増加する見込み
4.5.2 回復シナリオ (V, U, W, L)

5 生物製剤市場予測：用途別、2022-2032年
5.1 オンコロジー分野の市場予測、2022-2032年
5.1.1 生物学的がん治療は、がん細胞を認識し殺すために免疫系を訓練することを目的とする
5.1.2 回復シナリオ（V、U、W、L）
5.2 自己免疫疾患セグメントの市場予測、2022年～2032年
5.2.1 このセグメントにおける研究開発の増加
5.2.2 回復のシナリオ（V、U、W、L)
5.3 感染症治療薬セグメントの市場予測、2022年〜2032年
5.3.1 経口・非経口投与経路の代替可能性
5.3.2 回復シナリオ（V、U、W、L）
5.4 循環器疾患セグメントの市場予測、2022年〜2032年
5.4.1 循環器疾患は、世界の死因のトップになる
5.4.2 回復シナリオ（V、U、W、L）
5.5 血液疾患セグメント市場予測、2022年〜2032年
5.5.1 世界的な健康問題となった血液疾患
5.5.2 回復シナリオ（V,U,W,L）
5.6 その他セグメント市場予測、2022年〜2032年
5.6.1 血液疾患関連技術の採用がその他セグメントの成長を後押しする見込み
5.6.2 回復シナリオ（V,U,W,L)

6 生物製剤市場予測：製造別、2022-2032年
6.1 インハウス分野の市場予測、2022-2032年
6.1.1 インハウスが最大の売上シェアを占める
6.1.2 リカバリーシナリオ（V、U、W、L）
6.2 アウトソーシングセグメント市場予測、2022年～2032年
6.2.1 外用薬物送達の使い勝手の良さが外注市場を押し上げる
6.2.2 リカバリーシナリオ（V, U, W, L)

7 世界の生物製剤市場予測、2022-2032年
7.1 生物製剤世界地域別市場予測 2022-2032
7.2 回復シナリオ（V、U、W、L）

8 北米の生物製剤市場、2022-2032年
8.1 生物製剤の世界市場において北米が獲得した最大のシェア
8.2 北米生物製剤の国別市場規模予測（2022年〜2032年）
8.3 北米生物製剤の製品タイプ別市場予測
8.3.1 回復シナリオ（V、U、W、L）。北米生物製剤の製品タイプ別市場予測（2022年〜2032年）
8.4 北米の生物製剤の用途別市場予測
8.4.1 回復シナリオ（V,U,W,L)。北米の生物製剤の用途別市場予測（2022-2032年）
8.5 北米生物製剤の製造業別市場予測
8.5.1 回復シナリオ(V,U,W,L)。北米の生物製剤の製造業別市場予測（2022年〜2032年）
8.6 米国の生物製剤市場予測、2022年〜2032年
8.6.1 当地域の研究調査に対する公的・民間資金の増加
8.6.2 パンデミック対策のための予算要求
8.6.3 回復シナリオ（V、U、W、L）。米国の生物製剤市場の予測（2022年〜2032年）
8.7 カナダの生物製剤市場の予測、2022年〜2032年
8.7.1 地域全体での乾癬の有病率の高まりと関連する研究開発
8.7.2 カナダの医薬品支出の中で生物製剤は大きな割合を占めている
8.7.3 回復シナリオ（V、U、W、L）。カナダの生物製剤市場の予測（2022-2032年）

9 欧州の生物製剤市場、2022-2032年
9.1 先進的な生物製剤の地域全体での上市
9.2 欧州生物製剤の国別市場予測（2022年〜2032年）
9.3 欧州生物製剤の製品タイプ別市場予測
9.3.1 回復シナリオ（V、U、W、L）。欧州生物製剤の製品タイプ別市場予測（2022年〜2032年）
9.4 欧州の生物製剤の用途別市場予測
9.4.1 回復シナリオ（V、U、W、L）。欧州の生物製剤の用途別市場予測（2022年〜2032年）
9.5 欧州生物製剤の製造業別市場予測
9.5.1 回復シナリオ（V,U,W,L)。欧州生物製剤の製造業別市場予測（2022年〜2032年）
9.6 ドイツの生物製剤市場予測、2022年〜2032年
9.6.1 ドイツ政府による市場プレイヤーの製品開発への支援
9.6.2 回復シナリオ（V、U、W、L）。ドイツ生物製剤市場予測（2022年〜2032年）
9.7 英国生物製剤市場予測、2022年〜2032年
9.7.1 糖尿病と皮膚疾患の有病率の増加
9.7.2 回復シナリオ（V、U、W、L）:英国生物製剤市場の予測（2022年〜2032年）
9.8 フランスの生物製剤市場予測、2022年〜2032年
9.8.1 がん罹患率の上昇とフランス政府のがん対策戦略
9.8.2 回復シナリオ（V、U、W、L）。フランス生物製剤市場の予測（2022年〜2032年）
9.9 イタリアの生物製剤市場の予測、2022年〜2032年
9.9.1 癌の有病率の上昇
9.9.2 回復シナリオ（V、U、W、L）:イタリアの生物製剤市場の予測（2022年〜2032年）
9.10 スペインの生物製剤市場の予測、2022年〜2032年
9.10.1 感染症の負担増
9.10.2 回復シナリオ（V、U、W、L）:スペイン生物製剤市場の予測（2022年〜2032年）
9.11 ロシアの生物製剤市場予測、2022年〜2032年
9.11.1 デジタル化で大躍進
9.11.2 回復シナリオ（V,U,W,L）。ロシア生物製剤市場の予測（2022年〜2032年）
9.12 その他の欧州の生物製剤市場予測、2022年〜2032年
9.12.1 先進的な生物製剤の採用が進む
9.12.2 回復シナリオ（V、U、W、L）。その他の欧州の生物製剤市場の予測（2022年〜2032年）

10 アジア太平洋地域の生物製剤市場、2022-2032年
10.1 バイオロジクス APACはバイオロジクス市場のR＆Dと生産で最も成長する地域市場になる
10.2 アジア太平洋地域の生物製剤の国別市場予測（2022年〜2032年）
10.3 アジア太平洋地域の生物製剤市場の製品タイプ別予測
10.3.1 回復シナリオ（V、U、W、L）。アジア太平洋地域の生物製剤の製品タイプ別市場予測（2022年〜2032年）
10.4 アジア太平洋地域の生物製剤の用途別市場予測
10.4.1 回復シナリオ（V、U、W、L）。アジア太平洋地域の生物製剤の用途別市場予測（2022年〜2032年）
10.5 アジア太平洋地域の生物製剤の製造業別市場予測
10.5.1 回復シナリオ（V、U、W、L）。アジア太平洋地域の生物製剤の製造業別市場予測（2022年〜2032年）
10.6 日本の生物製剤市場予測（2022年〜2032年）
10.6.1 R＆Dに投資する主要な市場プレイヤー
10.6.2 回復シナリオ（V、U、W、L）:日本の生物製剤の市場予測（2022年〜2032年）
10.7 中国の生物製剤市場予測、2022年〜2032年
10.7.1 国内mAbパイプラインの急成長と規制改革が、中国の生物製剤CDMOにビジネスチャンスをもたらす
10.7.2 回復シナリオ(V、U、W、L):中国の生物製剤市場の予測（2022年〜2032年）
10.8 インドの生物製剤市場の予測、2022年〜2032年
10.8.1 インドの生物製剤市場は現在、単純な生物製剤が支配的
10.8.2 回復シナリオ(V,U,W,L):インドの生物製剤市場の予測（2022年〜2032年）
10.9 オーストラリアの生物製剤市場予測、2022年〜2032年
10.9.1 市場プレイヤーによる設備投資の拡大
10.9.2 回復シナリオ（V、U、W、L）:オーストラリア生物製剤市場の予測（2022年〜2032年）
10.10 韓国の生物製剤市場の予測、2022年〜2032年
10.10.1 韓国における癌の有病率の増加
10.10.2 回復シナリオ(V、U、W、L):韓国の生物製剤市場の予測（2022年〜2032年）
10.11 アジア太平洋地域のその他の生物製剤市場の予測（2022年〜2032年）
10.11.1 同地域における可処分所得の増加
10.11.2 回復シナリオ（V、U、W、L）。その他のアジア太平洋地域の生物製剤市場の予測（2022年〜2032年）

11 ラテンアメリカの生物製剤市場、2022-2032年
11.1 有利なCAGRで成長することが期待される中南米生物製剤市場
11.2 中南米生物製剤の国別市場予測（2022年〜2032年）
11.3 中南米の生物製剤市場の製品タイプ別予測
11.3.1 回復シナリオ（V、U、W、L）。中南米の生物製剤市場の製品タイプ別予測（2022年〜2032年）
11.4 中南米の生物製剤の用途別市場予測
11.4.1 回復シナリオ（V、U、W、L）。中南米の生物製剤の用途別市場予測（2022年〜2032年）
11.5 中南米の生物製剤の製造別市場予測
11.5.1 回復シナリオ(V, U, W, L)。中南米の生物製剤市場の予測（製造業別）（2022年〜2032年）
11.6 ブラジルの生物製剤市場予測、2022年〜2032年
11.6.1 高いポテンシャルを持つ製造環境
11.6.2 回復シナリオ（V、U、W、L）。ブラジル生物製剤市場の予測（2022年〜2032年）
11.7 メキシコの生物製剤市場予測、2022年〜2032年
11.7.1 メキシコの製造コストの低さ
11.7.2 回復シナリオ(V, U, W, L)。メキシコの生物製剤市場予測（2022年〜2032年）
11.8 その他のラテンアメリカの生物製剤市場予測（2022年〜2032年）
11.8.1 この地域の医療インフラは発展している
11.8.2 回復シナリオ（V、U、W、L）。その他のラテンアメリカの生物製剤市場の予測（2022年〜2032年）

12 MEAの生物製剤市場、2022-2032年
12.1 この地域における癌の発生率の増加
12.2 MEA生物製剤の国別市場予測（2022年〜2032年）
12.3 MEA生物製剤の製品タイプ別市場予測
12.3.1 回復シナリオ（V、U、W、L）。MEA生物製剤の製品タイプ別市場予測（2022年〜2032年）
12.4 MEAの生物製剤の用途別市場予測
12.4.1 回復シナリオ（V、U、W、L）。MEAの生物製剤の用途別市場予測（2022年〜2032年）
12.5 MEAの生物製剤の製造業別市場予測
12.5.1 回復シナリオ（V、U、W、L）。MEA生物製剤の製造業別市場予測（2022年〜2032年）
12.6 GCC生物製剤の市場予測（2022年〜2032年
12.6.1 ハグの成長機会の存在
12.6.2 回復シナリオ（V、U、W、L）。GCC生物製剤の市場予測（2022年〜2032年）
12.7 南アフリカの生物製剤市場予測（2022年〜2032年）
12.7.1 この南アフリカでは感染症が急増している
12.7.2 回復シナリオ（V、U、W、L）。南アフリカの生物製剤市場予測（2022年〜2032年）
12.8 MEAのその他の地域の生物製剤市場予測（2022年〜2032年）
12.8.1 その他のMEA地域では、癌が死因の主な原因の1つとなっている
12.8.2 回復のシナリオ（V、U、W、L）。その他のMEA地域の生物製剤市場の予測（2022年〜2032年）

13 主要企業のプロフィール
13.1 企業シェア分析
13.2 バイオロジクス市場の最近の動向
13.3 ジョンソン・エンド・ジョンソンサービス
13.3.1 企業スナップショット
13.3.2 会社概要
13.3.3 財務分析
13.3.3.1 純収益、2017年～2021年
13.3.3.2 地域別収益／マーケットシェア、2021年
13.3.3.3 セグメント別収益／マーケットシェア、2021年
13.3.4 製品ベンチマーク
13.3.5 最新の開発状況
13.4 メルクKGaA
13.4.1 企業スナップショット
13.4.2 会社概要
13.4.3 財務分析
13.4.3.1 純収益、2017-2021年
13.4.3.2 地域別収益／マーケットシェア、2021年
13.4.3.3 セグメント別収益／マーケットシェア、2021年
13.4.4 製品ベンチマーク
13.4.5 最新の開発状況
13.5 グラクソ・スミスクライン plc.
13.5.1 企業スナップショット
13.5.2 会社概要
13.5.3 財務分析
13.5.3.1 純収益、2017-2021年
13.5.3.2 地域別収益／市場シェア、2021年
13.5.3.3 セグメント別収益／マーケットシェア、2021年
13.5.4 製品ベンチマーク
13.5.5 最新の開発状況
13.6 ノバルティスAG
13.6.1 企業スナップショット
13.6.2 会社概要
13.6.3 財務分析
13.6.3.1 純収益、2017-2021年
13.6.3.2 地域別収益／マーケットシェア、2021年
13.6.3.3 セグメント別収益／マーケットシェア、2021年
13.6.4 製品ベンチマーク
13.6.5 最新の開発状況
13.7 F. ホフマン・ラ・ロシュ社
13.7.1 企業スナップショット
13.7.2 会社概要
13.7.3 財務分析
13.7.3.1 純収益、2017-2021年
13.7.3.2 セグメント別収益／マーケットシェア、2021年
13.7.3.3 地域別収益／マーケットシェア、2020年
13.7.4 製品ベンチマーク
13.7.5 最新の開発状況
13.8 ファイザー
13.8.1 企業スナップショット
13.8.2 会社概要
13.8.3 財務分析
13.8.3.1 純収益、2017-2021年
13.8.3.2 地域別収益／市場シェア、2021年
13.8.3.3 セグメント別収益／マーケットシェア、2021年
13.8.4 製品ベンチマーク
13.8.5 最新の開発状況
13.9 サノフィ
13.9.1 企業スナップショット
13.9.2 会社概要
13.9.3 財務分析
13.9.3.1 純収益、2017-2021年
13.9.3.2 地域別収益／マーケットシェア、2021年
13.9.3.3 セグメント別収益／マーケットシェア、2021年
13.9.4 製品ベンチマーク
13.9.5 最新の開発状況
13.10 ノボ・ホールディングスA/S（ノボノルディスクA/S）
13.10.1 企業スナップショット
13.10.2 会社概要
13.10.3 財務分析
13.10.3.1 純収益、2017年～2021年
13.10.3.2 地域別収益／市場シェア、2020年
13.10.3.3 セグメント別収益／市場シェア、2020年
13.10.4 製品ベンチマーク
13.10.5 最新の開発状況
13.11 武田薬品工業株式会社
13.11.1 会社概要
13.11.2 会社概要
13.11.3 財務分析
13.11.3.1 純収益、2017-2021年
13.11.3.2 地域別収益／マーケットシェア、2020年
13.11.3.3 セグメント別収益／マーケットシェア、2020年
13.11.4 製品のベンチマーキング
13.12 イーライリリー・アンド・カンパニー
13.12.1 企業スナップショット
13.12.2 会社概要
13.12.3 財務分析
13.12.3.1 純収益、2017-2021年
13.12.3.2 地域別収益／市場シェア、2020年
13.12.4 製品ベンチマーク
13.12.5 最近の開発状況
13.13 アムジェン社
13.13.1 企業スナップショット
13.13.2 会社概要
13.13.3 財務分析
13.13.3.1 純収益、2017-2021年
13.13.3.2 地域別収益シェア、2021年
13.13.3.3 セグメント収益シェア、2021年
13.13.4 製品ベンチマーク
13.13.5 最新の開発状況
13.14 ブリストル・マイヤーズスクイブ社
13.14.1 企業スナップショット
13.14.2 会社概要
13.14.3 財務分析
13.14.3.1 純収益、2017-2021年
13.14.3.2 地域別売上高シェア、2021年
13.14.4 製品ベンチマーク
13.14.5 最近の開発状況
13.15 バイオジェン
13.15.1 企業スナップショット
13.15.2 会社概要
13.15.3 財務分析
13.15.3.1 純収益、2017-2021年
13.15.3.2 地域別収益シェア、2021年
13.15.4 製品ベンチマーク
13.15.5 最近の開発状況
13.16 ヌーベーシブ社
13.16.1 企業スナップショット
13.16.2 会社概要
13.16.3 財務分析
13.16.3.1 純収益、2017年～2021年
13.16.3.2 地域別収益シェア、2021年
13.16.3.3 セグメント収益シェア、2021年
13.16.4 製品ベンチマーク
13.17 オルトフィックス・インターナショナル N.V.
13.17.1 企業スナップショット
13.17.2 会社概要
13.17.3 財務分析
13.17.3.1 純収益、2017-2021年
13.17.3.2 地域別売上高シェア、2021年
13.17.3.3 セグメント収益シェア、2020年
13.17.4 製品ベンチマーク
13.18 オルガノジェネシスホールディングス
13.18.1 企業スナップショット
13.18.2 会社概要
13.18.3 財務分析
13.18.3.1 純収益、2018-2021年
13.18.3.2 セグメント収益シェア、2021年
13.18.4 製品ベンチマーク
13.19 アッヴィー社
13.19.1 企業スナップショット
13.19.2 会社概要
13.19.3 財務分析
13.19.3.1 純収益、2017-2021年
13.19.3.2 地域別収益シェア、2021年
13.19.3.3 セグメント収益シェア、2021年
13.19.4 製品ベンチマーク
13.19.5 最新の開発状況

14 結論と提言
14.1 ビジョンゲインからの結論
14.2 市場関係者への提言

表の一覧
Table 1 Global Biologics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 3 Global Biologics examples of US FDA-approved monoclonal antibody present in the market, CAGR%)
Table 4 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 5 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 20 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 25 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 30 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Biologics Market for Autoimmune diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 46 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 56 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 1 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 60 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 61 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 66 Global Biologics Market for outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 North America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 76 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 82 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 87 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 97 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 102 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 103 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 104 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 105 Europe Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 106 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 108 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 113 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 118 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 123 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 128 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 133 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 138 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 143 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 148 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 154 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 159 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 164 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 169 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 174 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 179 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 184 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 189 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 194 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Latin America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 199 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 200 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 205 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 210 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 215 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 220 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 225 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 226 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 227 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 228 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 229 MEA Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 230 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 231 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 232 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 233 MEA Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 234 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 235 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 236 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 237 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 238 MEA Biologics Market Forecast by application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 239 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 240 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 241 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 242 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 243 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 244 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 245 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 246 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 248 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 249 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 250 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 251 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 252 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 253 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 254 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 256 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 260 Biologics Market Company Ranking for the Year 2021
Table 261 Biologics Market Recent Developments
Table 262 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Johnson & Johnson Services Inc.: Product Benchmarking
Table 264 Johnson & Johnson Services inc.: Recent Developments
Table 265 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 Merck KGaA: Product Benchmarking
Table 267 Merck KGaA: Recent Developments
Table 268 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 GlaxoSmithKline plc.: Product Benchmarking
Table 270 GlaxoSmithKline plc.: Recent Developments
Table 271 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 272 Novartis AG: Product Benchmarking
Table 273 Novartis AG: Recent Developments
Table 274 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 275 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 276 F. Hoffmann-La Roche Ltd: Recent Developments
Table 277 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Pfizer Inc.: Product Benchmarking
Table 279 Pfizer Inc.: Recent Developments
Table 280 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 281 Sanofi: Product Benchmarking
Table 282 Sanofi: Recent Developments
Table 283 Novo Holdings A/S (Novo Nordisk A/S): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 284 Novo Holdings A/S (Novo Nordisk A/S): Product Benchmarking
Table 285 Novo Holdings A/S (Novo Nordisk A/S): Recent Developments
Table 286 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 287 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 288 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Eli Lilly and Company: Product Benchmarking
Table 290 Eli Lilly and Company: Recent Developments
Table 291 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Amgen Inc.: Product Benchmarking
Table 293 Amgen Inc.: Recent Developments
Table 294 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Bristol-Myers Squibb Company: Product Benchmarking
Table 296 Bristol-Myers Squibb Company: Recent Developments
Table 297 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Biogen: Product Benchmarking
Table 299 Biogen: Recent Developments
Table 300 NuVasive, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 301 NuVasive, Inc.: Product Benchmarking
Table 302 ORTHOFIX INTERNATIONAL N. V. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 ORTHOFIX INTERNATIONAL N.V. : Product Benchmarking
Table 304 Organogenesis Holdings Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Organogenesis Holdings Inc. : Product Benchmarking
Table 306 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 AbbVie Inc.: Product Benchmarking
Table 308 AbbVie Inc. : Recent Developments

図の一覧
Figure 1 Global Biologics Market Segmentation
Figure 2 Global Biologics Market: Market Dynamics
Figure 3 Global Biologics Market: SWOT Analysis
Figure 4 Global Biologics Market: Porter’s Five Forces Analysis
Figure 5 Global Biologics Market: PEST Analysis
Figure 6 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 7 Global Biologics Market Share Forecast by Product Type, 2022, 2026, 2032 (%)
Figure 8 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 9 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Biologics Market for Vaccine Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 24 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 29 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR %)
Figure 34 Global Biologics Market Share Forecast by Application, 2022, 2026, 2032 (%)
Figure 35 Global Biologics Market for Oncology Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 36 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 41 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 46 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Biologics Market for Cardiovascular Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 51 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Biologics Market for Haematological Disorders Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Biologics Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 61 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 66 Global Biologics Market Share Forecast by Manufacturing, 2022, 2026, 2032 (%)
Figure 67 Global Biologics Market for In-house Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 68 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Biologics Market for Outsourced Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 73 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 74 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 75 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 76 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 77 Global Biologics Market Forecast by Region 2022-2032 (US$ billion)
Figure 78 Global Biologics Market Share Forecast by Region 2022, 2026, 2032 (%)
Figure 79 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 80 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 81 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 82 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 83 North America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 84 North America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 85 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 86 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 87 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 88 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 89 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 90 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 91 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 92 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 93 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 94 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 95 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 96 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 97 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 98 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 99 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 100 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 101 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 102 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 103 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 104 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 105 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 106 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 107 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 108 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 109 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 110 Europe Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 111 Europe Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 112 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 113 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 114 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 115 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 116 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 117 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 118 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 123 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 128 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 133 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 138 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 143 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 148 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 153 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 158 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Asia Pacific Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 163 Asia Pacific Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 164 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 165 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 166 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 167 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 168 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 169 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 170 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 171 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 172 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 173 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 174 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 175 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 176 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 177 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 178 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 179 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 180 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 181 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 182 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 183 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 184 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 185 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 186 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 187 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 188 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 189 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 190 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 191 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 192 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 193 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 194 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 195 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 200 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 205 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 Latin America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 210 Latin America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 211 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 212 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 213 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 214 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 215 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 216 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 217 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 218 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 219 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 220 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 221 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 222 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 223 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 224 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 225 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 226 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 227 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 228 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 229 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 230 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 231 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 232 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 233 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 234 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 235 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 236 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 237 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 238 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 239 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 240 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 241 MEA Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 242 MEA Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 243 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 244 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 245 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 246 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 247 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 248 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 249 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 250 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 251 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 252 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 253 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 254 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 255 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 256 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 257 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 258 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 259 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 260 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 261 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 262 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 263 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 264 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 265 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 266 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 267 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 268 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 269 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 270 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 271 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 272 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 273 Johnson & Johnson Services Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 274 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2021
Figure 275 Johnson & Johnson Services Inc.: Segmental Revenue Shares, 2021
Figure 276 Merck KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 277 Merck KGaA: Regional Revenue Shares, 2021
Figure 278 Merck KGaA: Segmental Revenue Shares, 2021
Figure 279 GlaxoSmithKline plc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 280 GlaxoSmithKline plc.: Regional Revenue Shares, 2021
Figure 281 GlaxoSmithKline plc.: Segmental Revenue Shares, 2021
Figure 282 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 283 Novartis AG: Regional Revenue Shares, 2021
Figure 284 Novartis AG: Segmental Revenue Shares, 2021
Figure 285 F. Hoffmann-La Roche Ltd. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 286 F. Hoffmann-La Roche Ltd: Segmental Revenue Shares, 2021
Figure 287 F. Hoffmann-La Roche Ltd: Regional Revenue Shares, 2021
Figure 288 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 289 Pfizer Inc.: Regional Revenue Shares, 2021
Figure 290 Pfizer Inc.: Segmental Revenue Shares, 2021
Figure 291 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 292 Sanofi: Regional Revenue Shares, 2021
Figure 293 Sanofi: Segmental Revenue Shares, 2021
Figure 294 Novo Holdings A/S (Novo Nordisk A/S): Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 295 Novo Holdings A/S (Novo Nordisk A/S): Regional Revenue Shares, 2020
Figure 296 Novo Holdings A/S (Novo Nordisk A/S): Segmental Revenue Shares, 2020
Figure 297 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 298 Takeda Pharmaceutical Company Limited: Regional Revenue Shares, 2020
Figure 299 Takeda Pharmaceutical Company Limited: Segmental Revenue Shares, 2020
Figure 300 Eli Lilly and Company: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 301 Eli Lilly and Company: Regional Revenue Shares, 2020
Figure 302 Amgen Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 303 Amgen Inc.: Regional Revenue Shares, 2021
Figure 304 Amgen Inc.: Segment Revenue Shares, 2021
Figure 305 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 306 Bristol-Myers Squibb Company: Regional Revenue Shares, 2021
Figure 307 Biogen: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 308 Biogen: Regional Revenue Shares, 2021
Figure 309 NuVasive, Inc.: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 310 NuVasive Inc.: Regional Revenue Shares, 2021
Figure 311 NuVasive Inc.: Segment Revenue Shares, 2021
Figure 312 ORTHOFIX INTERNATIONAL N.V. : Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 313 ORTHOFIX INTERNATIONAL N.V. : Regional Revenue Shares, 2021
Figure 314 ORTHOFIX INTERNATIONAL N.V. : Segment Revenue Shares, 2020
Figure 315 Organogenesis Holdings Inc. : Net Revenue, 2018-2021 (US $ million, AGR %)
Figure 316 Organogenesis Holdings Inc. : Segment Revenue Shares, 2021
Figure 317 AbbVie Inc. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 318 AbbVie Inc. : Regional Revenue Shares, 2021
Figure 319 AbbVie Inc. : Segment Revenue Shares, 2021
Figure 320 Global Biologics Market Share Forecast by Region, 2022, 2026, 2032 (%)

ページTOPに戻る

Table of Contents

Summary

この調査レポートは世界の生物製剤市場市場を調査し、製品タイプ別、用途別、製造別、地域別に2022年から2032年までの予測結果を掲載しています。また関連企業情報を提供しています。

主な掲載内容（目次より抜粋）

レポート概要
エグゼクティブサマリー
市場のダイナミックス
生物製剤市場予測：製品タイプ別、2022-2032年
生物製剤市場予測：用途別、2022-2032年
生物製剤市場予測：製造別、2022-2032年
世界の生物製剤市場予測、2022-2032年
北米の生物製剤市場、2022-2032年
欧州の生物製剤市場、2022-2032年
アジア太平洋地域の生物製剤市場、2022-2032年
ラテンアメリカの生物製剤市場、2022-2032年
MEAの生物製剤市場、2022-2032年
主要企業のプロフィール

Report Details

The Biologics Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Active R&D and Focus on Clinical Trials is Boosting the Biologics Market Growth
Active R&D and focus on clinical trials is driving the global biologics market growth. These R&D operations have resulted in increased success rates in biologic clinical studies. Industry leaders in the biologics market do R&D as they strive to produce market innovations in the form of effective and innovative biologics. Companies in the biologics sector have huge profit margins because of the high pricing of biologics and their efficacy. For decades, pharmaceutical corporations have focused on small compounds, but the rate of discovery in that sector has slowed drastically, resulting in a move toward biologics. Biologics therapy, which is roughly 20 times more expensive than small molecules, is predicted to create a profit margin of about 40%-45% in the future.

Logistical and Administrative Challenges
Governments and regulatory agencies play important roles in the biologics sector. Regulatory bodies maintain regulatory procedures for the development of new biologics markets for both existing and novel pharmaceuticals. Over the last decade, drug researchers have faced an increasing pushback in major markets for clinical studies of innovative biologics, which has hindered the launch of novel treatments for rare diseases. Strategic measures have been taken in these large markets, such as the United States and the European Union, to strengthen and liberalise regulatory regulations, hence simplifying clinical trial design. However, an increase in government spending for drug-related healthcare programmes is critical to industry success.

What Questions Should You Ask before Buying a Market Research Report?
• How is the biologics market evolving?
• What is driving and restraining the biologics market?
• How will each biologics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
• How will the market shares for each biologics submarket develop from 2022 to 2032?
• What will be the main driver for the overall market from 2022 to 2032?
• Will leading biologics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
• Who are the leading players and what are their prospects over the forecast period?
• What are the biologics projects for these leading companies?
• How will the industry evolve during the period between 2022 and 2032? What is the implication of biologics projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the biologics market?
• Where is the biologics market heading? And how can you ensure you are at the forefront of the market?
• What can be the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the biologics market today, and over the next 10 years:
• Our 475-page report provides 308 tables and 320 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• Contains in-depth analysis of global, regional and national sales and growth
• Highlights for you the key successful trends, changes and revenue projections made by your competitors

This report tells you TODAY how the biologics market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Delivers exclusive COVID-19 variations economic data specific to your market.

Forecasts to 2032 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising biologics prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report

Product Type
• Monoclonal Antibodies
• Vaccines
• Protein Therapeutics
• Fusion Proteins
• Regenerative Medicine

Application
• Oncology
• Autoimmune Disorder
• Infectious Diseases
• Cardiovascular Disorders
• Hematological Disorders
• Others

Manufacturing
• Outsourced
• In-house

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 20 leading national markets:

North America
• U.S.
• Canada

Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa
• GCC
• South Africa
• Rest of MEA

The report also includes profiles for some of the leading companies in the Biologics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.

Leading companies and the potential for market growth
• AbbVie Inc.
• Amgen Inc.
• Biogen
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc.
• Johnson & Johnson Services, Inc.
• Merck KGaA
• Novartis AG
• NuVasive, Inc.
• Novo Holdings A/S (Novo Nordisk A/S)
• Organogenesis Holdings Inc.
• ORTHOFIX INTERNATIONAL N.V.
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited

Overall world revenue for Biologics Market, 2022 to 2032 in terms of value the market will surpass US$382.85 billion in 2022, our work calculates. We predict strong revenue growth through 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Biologics Market, 2022 to 2032 Market report helps you?
In summary, our 470+ page report provides you with the following knowledge:

• Revenue forecasts to 2032 for Biologics Market, 2022 to 2032 Market, with forecasts for product type, application, and manufacturing each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues

• Revenue forecasts to 2032 for 5 regional and 22 key national markets – See forecasts for the Biologics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

• Prospects for established firms and those seeking to enter the market– including company profiles for 18 of the major companies involved in the Biologics Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our new report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biologics Market, 2022 to 2032 Market and leading companies. You will find data, trends and predictions.

ページTOPに戻る

Table of Contents

1. Report Overview
1.1 Introduction to Biologics Market
1.2 Biologics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain

2 Executive Summary

3 Market Dynamics
3.1 Drivers
3.1.1 Advancements in Biomedical Science
3.1.2 Increasing Funding for the Development of Novel Biologic Drugs
3.1.3 Several Drugs Going Off Patents
3.2 Restraints
3.2.1 High Stringency and Low Turnover for Clinical Trials
3.2.2 Development of Biosimilars will Reduce the Demand for Biological Drugs
3.3 Opportunities
3.3.1 Biologic Therapies are Becoming Relevant in a Greater Number of Disease Areas
3.4 Challenges
3.4.1 Complexity in Development of Biologics
3.5 SWOT Analysis
3.5.1 Strengths
3.5.1.1 Rising Need for Effective biologics Absorption and Convenient Self-Administration Emphasizes the Importance of the R&D Investment
3.5.2 Weaknesses
3.5.2.1 Financial Loss Due To Innovative Biologics Failure Has Been a Perennial Problem
3.5.3 Opportunities
3.5.3.1 Strong pipeline products and huge number of ongoing clinical trials are providing market growth opportunity.
3.5.3.2 Application of Nanotechnology in future
3.5.4 Threats
3.5.4.1 Small Molecules
3.6 Porter’s Five Forces Analysis
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyers: Moderate
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis
3.7.1 Political Factors Impacting Biologics Market
3.7.2 Economic Factors Impacting Biologics Market
3.7.3 Social Factors Impacting Biologics Market
3.7.4 Technological Factors Impacting Biologics Market

4 Biologics Market by Product Type Forecast, 2022-2032
4.1 Monoclonal Antibodies Segment Market Forecast, 2022-2032
4.1.1 Monoclonal Antibodies: Holds Largest Market Share
4.1.2 Recovery Scenarios (V, U, W, L)
4.2 Vaccine Segment Market Forecast, 2022-2032
4.2.1 Vaccine Manufacturing Remains Concentrated, With Four Large Manufacturers
4.2.2 Recovery Scenarios (V, U, W, L)
4.3 Protein Therapeutics Segment Market Forecast, 2022-2032
4.3.1 Increased public knowledge of the benefits of protein therapies
4.3.2 Recovery Scenarios (V, U, W, L)
4.4 Regenerative Medicines Segment Market Forecast, 2022-2032
4.4.1 Government policies favouring Regenerative Medicines
4.4.2 Recovery Scenarios (V, U, W, L)
4.5 Fusion Proteins Segment Market Forecast, 2022-2032
4.5.1 Rising prevalence of diabetes expected to boost demand of fusion proteins
4.5.2 Recovery Scenarios (V, U, W, L)

5 Biologics Market by Application Forecast, 2022-2032
5.1 Oncology Segment Market Forecast, 2022-2032
5.1.1 Biological cancer therapy aims to train the immune system to recognise and kill cancer cells
5.1.2 Recovery Scenarios (V, U, W, L)
5.2 Autoimmune Diseases Segment Market Forecast, 2022-2032
5.2.1 Increasing Research and Development in this segment
5.2.2 Recovery Scenarios (V, U, W, L)
5.3 Infectious Diseases Therapeutics Segment Market Forecast, 2022-2032
5.3.1 Possible alternative to oral and parenteral routes of administration
5.3.2 Recovery Scenarios (V, U, W, L)
5.4 Cardiovascular Diseases Segment Market Forecast, 2022-2032
5.4.1 Cardiovascular Disorders is becoming the top cause of death worldwide
5.4.2 Recovery Scenarios (V, U, W, L)
5.5 Haematological Disorders Segment Market Forecast, 2022-2032
5.5.1 Blood disorders became a worldwide health issue
5.5.2 Recovery Scenarios (V, U, W, L)
5.6 Others Segment Market Forecast, 2022-2032
5.6.1 Adoption Haematological Disorders Technologies is expected to boost the Others Segment Growth
5.6.2 Recovery Scenarios (V, U, W, L)

6 Biologics Market by Manufacturing Forecast, 2022-2032
6.1 In-house Segment Market Forecast, 2022-2032
6.1.1 In-house holds largest Revenue market share
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Outsourced Segment Market Forecast, 2022-2032
6.2.1 Ease of use of Topical drug delivery to boost the outsourced market
6.2.2 Recovery Scenarios (V, U, W, L)

7 Global Biologics Market Forecast, 2022-2032
7.1 Global Biologics Market by Region Forecast 2022-2032
7.2 Recovery Scenarios (V, U, W, L)

8 North America Biologics Market, 2022-2032
8.1 Largest share acquired by North America in Global Biologics Market
8.2 North America Biologics Market by Country, Forecast 2022-2032
8.3 North America Biologics Market Forecast by Product Type
8.3.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Product Type, 2022-2032
8.4 North America Biologics Market Forecast by Application
8.4.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Application, 2022-2032
8.5 North America Biologics Market Forecast by Manufacturing
8.5.1 Recovery Scenarios (V, U, W, L): North America Biologics Market Forecast by Manufacturing, 2022-2032
8.6 U.S. Biologics Market Forecast, 2022-2032
8.6.1 Growing public and private funding for research studies in this region
8.6.2 Budget request for Pandemic preparedness
8.6.3 Recovery Scenarios (V, U, W, L): U.S. Biologics Market Forecast, 2022-2032
8.7 Canada Biologics Market Forecast, 2022-2032
8.7.1 Growing Prevalence of Psoriasis and Related Research and Development across the Region
8.7.2 Biologics represent a large segment of drug spending in Canada
8.7.3 Recovery Scenarios (V, U, W, L): Canada Biologics Market Forecast, 2022-2032

9 Europe Biologics Market, 2022-2032
9.1 Launch of Advanced Biologics across the Region
9.2 Europe Biologics Market by Country, Forecast 2022-2032
9.3 Europe Biologics Market Forecast by Product Type
9.3.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Product Type, 2022-2032
9.4 Europe Biologics Market Forecast by Application
9.4.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Application, 2022-2032
9.5 Europe Biologics Market Forecast by Manufacturing
9.5.1 Recovery Scenarios (V, U, W, L): Europe Biologics Market Forecast by Manufacturing, 2022-2032
9.6 Germany Biologics Market Forecast, 2022-2032
9.6.1 German government support market player for product development
9.6.2 Recovery Scenarios (V, U, W, L): Germany Biologics Market Forecast, 2022-2032
9.7 U.K. Biologics Market Forecast, 2022-2032
9.7.1 Increase in prevalence of diabetes and skin conditions
9.7.2 Recovery Scenarios (V, U, W, L): U.K. Biologics Market Forecast, 2022-2032
9.8 France Biologics Market Forecast, 2022-2032
9.8.1 Growing cancer prevalence and French government cancer control strategy
9.8.2 Recovery Scenarios (V, U, W, L): France Biologics Market Forecast, 2022-2032
9.9 Italy Biologics Market Forecast, 2022-2032
9.9.1 Rising prevalence of cancer
9.9.2 Recovery Scenarios (V, U, W, L): Italy Biologics Market Forecast, 2022-2032
9.10 Spain Biologics Market Forecast, 2022-2032
9.10.1 Growing burden of Infectious diseases
9.10.2 Recovery Scenarios (V, U, W, L): Spain Biologics Market Forecast, 2022-2032
9.11 Russia Biologics Market Forecast, 2022-2032
9.11.1 Major leap forward in terms of Digitalization
9.11.2 Recovery Scenarios (V, U, W, L): Russia Biologics Market Forecast, 2022-2032
9.12 Rest of Europe Biologics Market Forecast, 2022-2032
9.12.1 Rising Adoption of Advanced Biologics
9.12.2 Recovery Scenarios (V, U, W, L): Rest of Europe Biologics Market Forecast, 2022-2032

10 Asia Pacific Biologics Market, 2022-2032
10.1 Biologics APAC will emerge as the fastest growing regional market for biologics market R&D and production
10.2 Asia Pacific Biologics Market by Country, Forecast 2022-2032
10.3 Asia Pacific Biologics Market Forecast by Product Type
10.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Product Type, 2022-2032
10.4 Asia Pacific Biologics Market Forecast by Application
10.4.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Application, 2022-2032
10.5 Asia Pacific Biologics Market Forecast by Manufacturing
10.5.1 Recovery Scenarios (V, U, W, L): Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032
10.6 Japan Biologics Market Forecast, 2022-2032
10.6.1 Major market players investing on R&D
10.6.2 Recovery Scenarios (V, U, W, L): Japan Biologics Market Forecast, 2022-2032
10.7 China Biologics Market Forecast, 2022-2032
10.7.1 Rapid growth of Domestic mAb pipeline and regulatory reform is creating business opportunities for Biologics CDMO’s in China
10.7.2 Recovery Scenarios (V, U, W, L): China Biologics Market Forecast, 2022-2032
10.8 India Biologics Market Forecast, 2022-2032
10.8.1 India Biologics market currently is dominated by Simple Biologics
10.8.2 Recovery Scenarios (V, U, W, L): India Biologics Market Forecast, 2022-2032
10.9 Australia Biologics Market Forecast, 2022-2032
10.9.1 Growing capital investment by the market player
10.9.2 Recovery Scenarios (V, U, W, L): Australia Biologics Market Forecast, 2022-2032
10.10 South Korea Biologics Market Forecast, 2022-2032
10.10.1 Increasing prevalence of Cancer in South Korea
10.10.2 Recovery Scenarios (V, U, W, L): South Korea Biologics Market Forecast, 2022-2032
10.11 Rest of Asia Pacific Biologics Market Forecast, 2022-2032
10.11.1 Rising Disposable Income in this region
10.11.2 Recovery Scenarios (V, U, W, L): Rest of Asia Pacific Biologics Market Forecast, 2022-2032

11 Latin America Biologics Market, 2022-2032
11.1 Latin America Biologics Market expected to grow at lucrative CAGR
11.2 Latin America Biologics Market by Country, Forecast 2022-2032
11.3 Latin America Biologics Market Forecast by Product Type
11.3.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Product Type, 2022-2032
11.4 Latin America Biologics Market Forecast by Application
11.4.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Application, 2022-2032
11.5 Latin America Biologics Market Forecast by Manufacturing
11.5.1 Recovery Scenarios (V, U, W, L): Latin America Biologics Market Forecast by Manufacturing, 2022-2032
11.6 Brazil Biologics Market Forecast, 2022-2032
11.6.1 High Potential Manufacturing Environment
11.6.2 Recovery Scenarios (V, U, W, L): Brazil Biologics Market Forecast, 2022-2032
11.7 Mexico Biologics Market Forecast, 2022-2032
11.7.1 Lower Manufacturing Cost in Mexico
11.7.2 Recovery Scenarios (V, U, W, L): Mexico Biologics Market Forecast, 2022-2032
11.8 Rest of Latin America Biologics Market Forecast, 2022-2032
11.8.1 Developing Healthcare Infrastructure in this region
11.8.2 Recovery Scenarios (V, U, W, L): Rest of Latin America Biologics Market Forecast, 2022-2032

12 MEA Biologics Market, 2022-2032
12.1 Increasing occurrence of Cancer in this region
12.2 MEA Biologics Market by Country, Forecast 2022-2032
12.3 MEA Biologics Market Forecast by Product Type
12.3.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Product Type, 2022-2032
12.4 MEA Biologics Market Forecast by Application
12.4.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Application, 2022-2032
12.5 MEA Biologics Market Forecast by Manufacturing
12.5.1 Recovery Scenarios (V, U, W, L): MEA Biologics Market Forecast by Manufacturing, 2022-2032
12.6 GCC Biologics Market Forecast, 2022-2032
12.6.1 Presence of Hug Growth Opportunities
12.6.2 Recovery Scenarios (V, U, W, L): GCC Biologics Market Forecast, 2022-2032
12.7 South Africa Biologics Market Forecast, 2022-2032
12.7.1 Rapidly increasing infectious diseases in this South Africa
12.7.2 Recovery Scenarios (V, U, W, L): South Africa Biologics Market Forecast, 2022-2032
12.8 Rest of MEA Biologics Market Forecast, 2022-2032
12.8.1 Cancer is one of the main reason of Death causes in Rest of MEA
12.8.2 Recovery Scenarios (V, U, W, L): Rest of MEA Biologics Market Forecast, 2022-2032

13 Company Profiles
13.1 Company Share Analysis
13.2 Biologics Market Recent Developments
13.3 Johnson & Johnson Services, Inc.
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2017-2021
13.3.3.2 Regional Revenue/Market Shares, 2021
13.3.3.3 Segmental Revenue/Market Shares, 2021
13.3.4 Product Benchmarking
13.3.5 Recent Developments
13.4 Merck KGaA
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2017-2021
13.4.3.2 Regional Revenue/Market Shares, 2021
13.4.3.3 Segmental Revenue/Market Shares, 2021
13.4.4 Product Benchmarking
13.4.5 Recent Developments
13.5 GlaxoSmithKline plc.
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2017-2021
13.5.3.2 Regional Revenue/Market Shares, 2021
13.5.3.3 Segmental Revenue/Market Shares, 2021
13.5.4 Product Benchmarking
13.5.5 Recent Developments
13.6 Novartis AG
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2017-2021
13.6.3.2 Regional Revenue/Market Shares, 2021
13.6.3.3 Segmental Revenue/Market Shares, 2021
13.6.4 Product Benchmarking
13.6.5 Recent Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2017-2021
13.7.3.2 Segmental Revenue/Market Shares, 2021
13.7.3.3 Regional Revenue/Market Shares, 2020
13.7.4 Product Benchmarking
13.7.5 Recent Developments
13.8 Pfizer Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2017-2021
13.8.3.2 Regional Revenue/Market Shares, 2021
13.8.3.3 Segmental Revenue/Market Shares, 2021
13.8.4 Product Benchmarking
13.8.5 Recent Developments
13.9 Sanofi
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2017-2021
13.9.3.2 Regional Revenue/Market Shares, 2021
13.9.3.3 Segmental Revenue/Market Shares, 2021
13.9.4 Product Benchmarking
13.9.5 Recent Developments
13.10 Novo Holdings A/S (Novo Nordisk A/S)
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2017-2021
13.10.3.2 Regional Revenue/Market Shares, 2020
13.10.3.3 Segmental Revenue/Market Shares, 2020
13.10.4 Product Benchmarking
13.10.5 Recent Developments
13.11 Takeda Pharmaceutical Company Limited
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Financial Analysis
13.11.3.1 Net Revenue, 2017-2021
13.11.3.2 Regional Revenue/Market Shares, 2020
13.11.3.3 Segmental Revenue/Market Shares, 2020
13.11.4 Product Benchmarking
13.12 Eli Lilly and Company
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Financial Analysis
13.12.3.1 Net Revenue, 2017-2021
13.12.3.2 Regional Revenue/Market Shares, 2020
13.12.4 Product Benchmarking
13.12.5 Recent Developments
13.13 Amgen Inc.
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Financial Analysis
13.13.3.1 Net Revenue, 2017-2021
13.13.3.2 Regional Revenue Shares, 2021
13.13.3.3 Segment Revenue Shares, 2021
13.13.4 Product Benchmarking
13.13.5 Recent Developments
13.14 Bristol-Myers Squibb Company
13.14.1 Company Snapshot
13.14.2 Company Overview
13.14.3 Financial Analysis
13.14.3.1 Net Revenue, 2017-2021
13.14.3.2 Regional Revenue Shares, 2021
13.14.4 Product Benchmarking
13.14.5 Recent Developments
13.15 Biogen
13.15.1 Company Snapshot
13.15.2 Company Overview
13.15.3 Financial Analysis
13.15.3.1 Net Revenue, 2017-2021
13.15.3.2 Regional Revenue Shares, 2021
13.15.4 Product Benchmarking
13.15.5 Recent Developments
13.16 NuVasive, Inc.
13.16.1 Company Snapshot
13.16.2 Company Overview
13.16.3 Financial Analysis
13.16.3.1 Net Revenue, 2017-2021
13.16.3.2 Regional Revenue Shares, 2021
13.16.3.3 Segment Revenue Shares, 2021
13.16.4 Product Benchmarking
13.17 ORTHOFIX INTERNATIONAL N.V.
13.17.1 Company Snapshot
13.17.2 Company Overview
13.17.3 Financial Analysis
13.17.3.1 Net Revenue, 2017-2021
13.17.3.2 Regional Revenue Shares, 2021
13.17.3.3 Segment Revenue Shares, 2020
13.17.4 Product Benchmarking
13.18 Organogenesis Holdings Inc.
13.18.1 Company Snapshot
13.18.2 Company Overview
13.18.3 Financial Analysis
13.18.3.1 Net Revenue, 2018-2021
13.18.3.2 Segment Revenue Shares, 2021
13.18.4 Product Benchmarking
13.19 AbbVie Inc.
13.19.1 Company Snapshot
13.19.2 Company Overview
13.19.3 Financial Analysis
13.19.3.1 Net Revenue, 2017-2021
13.19.3.2 Regional Revenue Shares, 2021
13.19.3.3 Segment Revenue Shares, 2021
13.19.4 Product Benchmarking
13.19.5 Recent Developments

14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players

List of Tables
Table 1 Global Biologics Market Snapshot, 2022 & 2032 (US$ billion, CAGR %)
Table 2 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 3 Global Biologics examples of US FDA-approved monoclonal antibody present in the market, CAGR%)
Table 4 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 5 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 6 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 7 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 8 Global Biologics Market for Monoclonal Antibodies Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 9 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 10 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 11 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 12 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 13 Global Biologics Market for Vaccine Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 14 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 15 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 16 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 17 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 18 Global Biologics Market for Protein Therapeutics Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 19 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 20 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 21 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 22 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 23 Global Biologics Market for Regenerative Medicines Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 24 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 25 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 26 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 27 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 28 Global Biologics Market for Fusion Proteins Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 29 Global Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 30 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 31 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Biologics Market for Oncology Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 36 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Biologics Market for Autoimmune diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Biologics Market for Autoimmune Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 41 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 42 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 43 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 44 Global Biologics Market for Infectious Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 45 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 46 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 47 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 48 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 49 Global Biologics Market for Cardiovascular Diseases Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 50 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 51 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 52 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 53 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 54 Global Biologics Market for Haematological Disorders Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 55 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 56 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 1 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 57 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 58 Global Biologics Market for Others Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 59 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 60 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 61 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 62 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 63 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 64 Global Biologics Market for In-house Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 65 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 66 Global Biologics Market for outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 67 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 68 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 69 Global Biologics Market for Outsourced Segment Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 70 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 71 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 72 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 73 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 74 Global Biologics Market Forecast by Region, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 75 North America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 76 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 77 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 78 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 79 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 80 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 81 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 82 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 83 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 84 North America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 85 North America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 86 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 87 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 88 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 89 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 90 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 91 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 92 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 93 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 94 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 95 U.S. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 96 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 97 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 98 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 99 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 100 Canada Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 101 Europe Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 102 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 103 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 104 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 105 Europe Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 106 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 107 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 108 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 109 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 110 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 111 Europe Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 112 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 113 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 114 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 115 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 116 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 117 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 118 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 119 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 120 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 121 Germany Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 122 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 123 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 124 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 125 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 126 U.K. Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 127 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 128 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 129 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 130 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 131 France Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 132 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 133 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 134 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 135 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 136 Italy Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 137 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 138 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 139 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 140 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 141 Spain Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 142 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 143 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 144 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 145 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 146 Russia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 147 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 148 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 149 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 150 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 151 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 152 Asia Pacific Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 154 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 155 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 156 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 157 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 158 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 159 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 160 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 161 Asia Pacific Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 162 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 163 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 164 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 165 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 166 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 167 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 168 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 169 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 170 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 171 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 172 Japan Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 173 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 174 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 175 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 176 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 177 China Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 178 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 179 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 180 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 181 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 182 India Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 183 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 184 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 185 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 186 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 187 Australia Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 188 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 189 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 190 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 191 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 192 South Korea Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 193 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 194 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 195 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 196 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 197 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 198 Latin America Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 199 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 200 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 201 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 202 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 203 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 204 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 205 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 206 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 207 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 208 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 209 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 210 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 211 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 212 Latin America Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 213 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 214 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 215 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 216 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 217 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 218 Brazil Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 219 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 220 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 221 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 222 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 223 Mexico Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 224 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 225 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 226 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 227 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 228 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 229 MEA Biologics Market Forecast by Country, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 230 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 231 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 232 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 233 MEA Biologics Market Forecast by Product Types, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 234 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 235 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 236 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 237 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 238 MEA Biologics Market Forecast by application, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 239 MEA Biologics Market Forecast by Application, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 240 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR %)
Table 241 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 242 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 243 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 244 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 245 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 246 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 247 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 248 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 249 GCC Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 250 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 251 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 252 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 253 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 254 South Africa Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 255 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%)
Table 256 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 257 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 258 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 259 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 260 Biologics Market Company Ranking for the Year 2021
Table 261 Biologics Market Recent Developments
Table 262 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Johnson & Johnson Services Inc.: Product Benchmarking
Table 264 Johnson & Johnson Services inc.: Recent Developments
Table 265 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 Merck KGaA: Product Benchmarking
Table 267 Merck KGaA: Recent Developments
Table 268 GlaxoSmithKline plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 GlaxoSmithKline plc.: Product Benchmarking
Table 270 GlaxoSmithKline plc.: Recent Developments
Table 271 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 272 Novartis AG: Product Benchmarking
Table 273 Novartis AG: Recent Developments
Table 274 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 275 F. Hoffmann-La Roche Ltd: Product Benchmarking
Table 276 F. Hoffmann-La Roche Ltd: Recent Developments
Table 277 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 278 Pfizer Inc.: Product Benchmarking
Table 279 Pfizer Inc.: Recent Developments
Table 280 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 281 Sanofi: Product Benchmarking
Table 282 Sanofi: Recent Developments
Table 283 Novo Holdings A/S (Novo Nordisk A/S): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 284 Novo Holdings A/S (Novo Nordisk A/S): Product Benchmarking
Table 285 Novo Holdings A/S (Novo Nordisk A/S): Recent Developments
Table 286 Takeda Pharmaceutical Company Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 287 Takeda Pharmaceutical Company Limited: Product Benchmarking
Table 288 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 289 Eli Lilly and Company: Product Benchmarking
Table 290 Eli Lilly and Company: Recent Developments
Table 291 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 292 Amgen Inc.: Product Benchmarking
Table 293 Amgen Inc.: Recent Developments
Table 294 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 295 Bristol-Myers Squibb Company: Product Benchmarking
Table 296 Bristol-Myers Squibb Company: Recent Developments
Table 297 Biogen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 298 Biogen: Product Benchmarking
Table 299 Biogen: Recent Developments
Table 300 NuVasive, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 301 NuVasive, Inc.: Product Benchmarking
Table 302 ORTHOFIX INTERNATIONAL N. V. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 303 ORTHOFIX INTERNATIONAL N.V. : Product Benchmarking
Table 304 Organogenesis Holdings Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 305 Organogenesis Holdings Inc. : Product Benchmarking
Table 306 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 307 AbbVie Inc.: Product Benchmarking
Table 308 AbbVie Inc. : Recent Developments

List of Figures
Figure 1 Global Biologics Market Segmentation
Figure 2 Global Biologics Market: Market Dynamics
Figure 3 Global Biologics Market: SWOT Analysis
Figure 4 Global Biologics Market: Porter’s Five Forces Analysis
Figure 5 Global Biologics Market: PEST Analysis
Figure 6 Global Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 7 Global Biologics Market Share Forecast by Product Type, 2022, 2026, 2032 (%)
Figure 8 Global Biologics Market for Monoclonal Antibodies Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 9 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 10 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 11 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 12 Global Biologics Market for Monoclonal Antibodies Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 13 Global Biologics Market for Vaccine Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 14 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 15 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 16 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 17 Global Biologics Market for Vaccine Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 18 Global Biologics Market for Protein Therapeutics Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 19 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 20 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 21 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 22 Global Biologics Market for Protein Therapeutics Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 23 Global Biologics Market for Regenerative Medicines Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 24 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 25 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 26 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 27 Global Biologics Market for Regenerative Medicines Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 28 Global Biologics Market for Fusion Proteins Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 29 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 30 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 31 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 32 Global Biologics Market for Fusion Proteins Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 33 Global Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR %)
Figure 34 Global Biologics Market Share Forecast by Application, 2022, 2026, 2032 (%)
Figure 35 Global Biologics Market for Oncology Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 36 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 37 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 38 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 39 Global Biologics Market for Oncology Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 40 Global Biologics Market for Autoimmune Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 41 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 42 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 43 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 44 Global Biologics Market for Autoimmune Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 45 Global Biologics Market for Infectious Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 46 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 47 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 48 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 49 Global Biologics Market for Infectious Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 50 Global Biologics Market for Cardiovascular Diseases Segment: Revenue Forecast 2022-2032 (US$ billion, AGR%)
Figure 51 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 52 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 53 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 54 Global Biologics Market for Cardiovascular Diseases Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 55 Global Biologics Market for Haematological Disorders Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 56 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 57 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 58 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 59 Global Biologics Market for Haematological Disorders Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 60 Global Biologics Market for Others Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 61 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 62 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 63 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 64 Global Biologics Market for Others Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 65 Global Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 66 Global Biologics Market Share Forecast by Manufacturing, 2022, 2026, 2032 (%)
Figure 67 Global Biologics Market for In-house Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 68 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 69 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 70 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 71 Global Biologics Market for In-house Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 72 Global Biologics Market for Outsourced Segment: Revenue Forecast 2022-2032 (US$ billion, AGR %)
Figure 73 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 74 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 75 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 76 Global Biologics Market for Outsourced Segment, Revenue Forecast 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 77 Global Biologics Market Forecast by Region 2022-2032 (US$ billion)
Figure 78 Global Biologics Market Share Forecast by Region 2022, 2026, 2032 (%)
Figure 79 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 80 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 81 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 82 Global Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 83 North America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 84 North America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 85 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR %)
Figure 86 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 87 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 88 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 89 North America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 90 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 91 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 92 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 93 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 94 North America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 95 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 96 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 97 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 98 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 99 North America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 100 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 101 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 102 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 103 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 104 U.S. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 105 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 106 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 107 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 108 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 109 Canada Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 110 Europe Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 111 Europe Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 112 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 113 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 114 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 115 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 116 Europe Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 117 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 118 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 119 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 120 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 121 Europe Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 122 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 123 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 124 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 125 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 126 Europe Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 127 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 128 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 129 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 130 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 131 Germany Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 132 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 133 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 134 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 135 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 136 U.K. Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 137 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 138 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 139 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 140 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 141 France Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 142 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 143 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 144 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 145 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 146 Italy Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 147 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 148 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 149 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 150 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 151 Spain Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 152 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 153 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 154 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 155 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 156 Russia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 157 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 158 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 159 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 160 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 161 Rest of Europe Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 162 Asia Pacific Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 163 Asia Pacific Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 164 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 165 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 166 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 167 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 168 Asia Pacific Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 169 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 170 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 171 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 172 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 173 Asia Pacific Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 174 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 175 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 176 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 177 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 178 Asia Pacific Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 179 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 180 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 181 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 182 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 183 Japan Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 184 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 185 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 186 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 187 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 188 China Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 189 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 190 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 191 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 192 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 193 India Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 194 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 195 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 196 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 197 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 198 Australia Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 199 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 200 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 201 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 202 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 203 South Korea Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 204 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 205 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 206 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 207 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 208 Rest of Asia Pacific Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 209 Latin America Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 210 Latin America Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 211 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 212 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 213 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 214 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 215 Latin America Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 216 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 217 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 218 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 219 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 220 Latin America Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 221 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%)
Figure 222 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 223 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 224 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 225 Latin America Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 226 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 227 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 228 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 229 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 230 Brazil Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 231 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 232 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 233 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 234 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 235 Mexico Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 236 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 237 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 238 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 239 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 240 Rest of Latin America Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 241 MEA Biologics Market Forecast by Country 2022-2032 (US$ billion)
Figure 242 MEA Biologics Market Share Forecast by Country 2022, 2026, 2032 (%)
Figure 243 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%)
Figure 244 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 245 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 246 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 247 MEA Biologics Market Forecast by Product Type, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 248 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%)
Figure 249 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 250 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 251 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 252 MEA Biologics Market Forecast by Application, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 253 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR %)
Figure 254 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 255 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 256 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 257 MEA Biologics Market Forecast by Manufacturing, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 258 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 259 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 260 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 261 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 262 GCC Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 263 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 264 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 265 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 266 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 267 South Africa Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 268 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR %)
Figure 269 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “V” Shaped Recovery
Figure 270 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “U” Shaped Recovery
Figure 271 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “W” Shaped Recovery
Figure 272 Rest of MEA Biologics Market Forecast, 2022-2032 (US$ billion, AGR%): “L” Shaped Recovery
Figure 273 Johnson & Johnson Services Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 274 Johnson & Johnson Services Inc.: Regional Revenue Shares, 2021
Figure 275 Johnson & Johnson Services Inc.: Segmental Revenue Shares, 2021
Figure 276 Merck KGaA: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 277 Merck KGaA: Regional Revenue Shares, 2021
Figure 278 Merck KGaA: Segmental Revenue Shares, 2021
Figure 279 GlaxoSmithKline plc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 280 GlaxoSmithKline plc.: Regional Revenue Shares, 2021
Figure 281 GlaxoSmithKline plc.: Segmental Revenue Shares, 2021
Figure 282 Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 283 Novartis AG: Regional Revenue Shares, 2021
Figure 284 Novartis AG: Segmental Revenue Shares, 2021
Figure 285 F. Hoffmann-La Roche Ltd. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 286 F. Hoffmann-La Roche Ltd: Segmental Revenue Shares, 2021
Figure 287 F. Hoffmann-La Roche Ltd: Regional Revenue Shares, 2021
Figure 288 Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 289 Pfizer Inc.: Regional Revenue Shares, 2021
Figure 290 Pfizer Inc.: Segmental Revenue Shares, 2021
Figure 291 Sanofi: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 292 Sanofi: Regional Revenue Shares, 2021
Figure 293 Sanofi: Segmental Revenue Shares, 2021
Figure 294 Novo Holdings A/S (Novo Nordisk A/S): Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 295 Novo Holdings A/S (Novo Nordisk A/S): Regional Revenue Shares, 2020
Figure 296 Novo Holdings A/S (Novo Nordisk A/S): Segmental Revenue Shares, 2020
Figure 297 Takeda Pharmaceutical Company Limited: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 298 Takeda Pharmaceutical Company Limited: Regional Revenue Shares, 2020
Figure 299 Takeda Pharmaceutical Company Limited: Segmental Revenue Shares, 2020
Figure 300 Eli Lilly and Company: Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 301 Eli Lilly and Company: Regional Revenue Shares, 2020
Figure 302 Amgen Inc.: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 303 Amgen Inc.: Regional Revenue Shares, 2021
Figure 304 Amgen Inc.: Segment Revenue Shares, 2021
Figure 305 Bristol-Myers Squibb Company: Net Revenue, 2017-2021 (US$ million, AGR%)
Figure 306 Bristol-Myers Squibb Company: Regional Revenue Shares, 2021
Figure 307 Biogen: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 308 Biogen: Regional Revenue Shares, 2021
Figure 309 NuVasive, Inc.: Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 310 NuVasive Inc.: Regional Revenue Shares, 2021
Figure 311 NuVasive Inc.: Segment Revenue Shares, 2021
Figure 312 ORTHOFIX INTERNATIONAL N.V. : Net Revenue, 2017-2021 (US $ million, AGR %)
Figure 313 ORTHOFIX INTERNATIONAL N.V. : Regional Revenue Shares, 2021
Figure 314 ORTHOFIX INTERNATIONAL N.V. : Segment Revenue Shares, 2020
Figure 315 Organogenesis Holdings Inc. : Net Revenue, 2018-2021 (US $ million, AGR %)
Figure 316 Organogenesis Holdings Inc. : Segment Revenue Shares, 2021
Figure 317 AbbVie Inc. : Net Revenue, 2017-2021 (US$ million, AGR %)
Figure 318 AbbVie Inc. : Regional Revenue Shares, 2021
Figure 319 AbbVie Inc. : Segment Revenue Shares, 2021
Figure 320 Global Biologics Market Share Forecast by Region, 2022, 2026, 2032 (%)

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

皮膚科治療薬市場レポート：2024-2034

Visiongain社の医薬・化学品分野での最新刊レポート

本レポートと同じKEY WORD（biologics）の最新刊レポート

よくあるご質問

Visiongain社はどのような調査会社ですか?

英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。